Literature DB >> 22251521

Fourteen year surgical experience of gallbladder cancer: validity of curative resection affecting survival.

Sae Byeol Choi1, Hyung Joon Han, Chung Yun Kim, Wan Bae Kim, Tae-Jin Song, Sung Ock Suh, Young Chul Kim, Sang Yong Choi.   

Abstract

BACKGROUND/AIMS: Early diagnosis and R0 resection of gallbladder cancer offer a chance for cure. The aims of this retrospective study were to determine the clinicopathologic prognostic factors affecting survival and recurrence.
METHODOLOGY: Between 1995 and 2008, a total of 69 patients with gallbladder cancer who underwent surgical exploration or resection were reviewed retrospectively.
RESULTS: Of the 69 patients, 34 achieved R0 resection (49.3%). The overall survival rates were 36.6% at 3 years and 24.4 % at 5 years. Multivariate analysis for overall survival demonstrated that non-R0 resection, lymph node dissection, infiltrative tumors, moderate to poor differentiation and depth of invasion were significant independent predictors of poor prognosis. Recurrence occurred in 21 patients. The seventh edition of American Joint Committee on Cancer staging system provided relatively better prediction of survival in patients with gallbladder cancer.
CONCLUSIONS: R0 resection and lymph node dissection is an important surgical strategy to improve overall survival. Infiltrative tumor was an independent prognostic factor for disease free survival.

Entities:  

Mesh:

Year:  2012        PMID: 22251521     DOI: 10.5754/hge10297

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  9 in total

1.  Metachronous pancreatic head ductal carcinoma three years after resection of gallbladder cancer.

Authors:  Dingwei Chen; Jiafei Yan; Yiping Mou
Journal:  Int J Clin Exp Med       Date:  2013-09-25

2.  Comparison of the sixth and seventh editions of the AJCC TNM classification for gallbladder cancer.

Authors:  Tak Geun Oh; Moon Jae Chung; Seungmin Bang; Seung Woo Park; Jae Bok Chung; Si Young Song; Gi Hong Choi; Kyung Sik Kim; Woo Jung Lee; Jeong Youp Park
Journal:  J Gastrointest Surg       Date:  2013-01-09       Impact factor: 3.452

3.  Radical lymph node dissection and assessment: Impact on gallbladder cancer prognosis.

Authors:  Gui-Jie Liu; Xue-Hua Li; Yan-Xin Chen; Hui-Dong Sun; Gui-Mei Zhao; San-Yuan Hu
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

4.  Laparoscopic radical cholecystectomy for suspected early gall bladder carcinoma: thinking beyond convention.

Authors:  Senthilnathan Palanisamy; Nikunj Patel; Sandeep Sabnis; Nalankilli Palanisamy; Anand Vijay; Praveenraj Palanivelu; R Parthasarthi; Palanivelu Chinnusamy
Journal:  Surg Endosc       Date:  2015-09-28       Impact factor: 4.584

5.  Prognostic significance of preoperative platelet count in patients with gallbladder cancer.

Authors:  Rui-Tao Wang; Ling-Qiang Zhang; Yi-Ping Mu; Jian-Bo Li; Xin-Sen Xu; Qing Pang; Lian-Kang Sun; Xing Zhang; Shun-Bin Dong; Lin Wang; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

Review 6.  Current Role of Minimally Invasive Radical Cholecystectomy for Gallbladder Cancer.

Authors:  Giuseppe Zimmitti; Alberto Manzoni; Francesca Guerini; Marco Ramera; Paola Bertocchi; Francesca Aroldi; Alberto Zaniboni; Edoardo Rosso
Journal:  Gastroenterol Res Pract       Date:  2016-11-03       Impact factor: 2.260

Review 7.  Robot-assisted radical cholecystectomy for gallbladder cancer: A review.

Authors:  Weng Jiayi; Vishal G Shelat
Journal:  J Clin Transl Res       Date:  2022-02-02

8.  Surgical outcome and prognostic factors in patients with gallbladder carcinoma.

Authors:  Eun Kyung Hong; Kun Kuk Kim; Jung Nam Lee; Woon Kee Lee; Min Chung; Yeon Suk Kim; Yeon Ho Park
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2014-11-30

9.  Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients.

Authors:  Wei-Yu Xu; Hao-Hai Zhang; Xiao-Bo Yang; Yi Bai; Jian-Zhen Lin; Jun-Yu Long; Jian-Ping Xiong; Jun-Wei Zhang; Xin-Ting Sang; Hai-Tao Zhao
Journal:  World J Gastroenterol       Date:  2018-04-07       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.